Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetic retinopathy.

J C Folk1, C F Blodi, J S Pulido

  • 1University of Iowa, Department of Opthalmology, Iowa City.

Iowa Medicine : Journal of the Iowa Medical Society
|November 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Visual impairment and self-limited placoid neuroretinitis as a possible early sign of COVID-19: A case report and multimodal analysis.

Journal francais d'ophtalmologie·2023
Same author

Dermal and conjunctival melanocytic proliferations in diffuse uveal melanocytic proliferation.

Eye (London, England)·2013
Same author

Reticular pseudodrusen: a tale of two species?

Eye (London, England)·2013
Same author

The effects of intraocular silicone oil placement prior to iodine 125 brachytherapy for uveal melanoma: a clinical case series.

Eye (London, England)·2012
Same author

Histological findings of birdshot chorioretinopathy in an eye with ciliochoroidal melanoma.

Eye (London, England)·2012
Same author

Anterior segment changes following intravitreal bevacizumab injection for treatment of neovascular glaucoma.

Clinical ophthalmology (Auckland, N.Z.)·2011
Same journal

CONTENT MARKETING How Your Medical Practice Can Benefit.

Iowa medicine : journal of the Iowa Medical Society·2018
Same journal

A NATIONAL UPSET The Remedy Starts Here.

Iowa medicine : journal of the Iowa Medical Society·2018
Same journal

RENEWING PASSION AND PURPOSE IN PRACTICE.

Iowa medicine : journal of the Iowa Medical Society·2018
Same journal

CANDOR PILOT SITE A SUCCESS IMS receives grant tofurther Candor education.

Iowa medicine : journal of the Iowa Medical Society·2018
Same journal

A PRESCRIPTION FOR PROFESSIONAL BURNOUT.

Iowa medicine : journal of the Iowa Medical Society·2018
Same journal

TO MAKE AN END IS TO MAKE A BEGINNING.

Iowa medicine : journal of the Iowa Medical Society·2018
See all related articles

Diabetic macular edema and proliferative retinopathy can cause blurred vision and blindness. Early focal laser treatment for macular edema and scatter laser treatment for proliferative disease significantly reduce vision loss, preventing blindness in diabetic patients.

Area of Science:

  • Ophthalmology
  • Diabetology
  • Retinal Diseases

Background:

  • Diabetic macular edema (DME) and proliferative retinopathy are leading causes of vision loss in diabetics.
  • DME often presents with blurred vision and retinal changes, particularly in maturity-onset diabetics.
  • Proliferative retinopathy, a more advanced stage, can lead to severe visual impairment or blindness if untreated.

Purpose of the Study:

  • To highlight the importance of early detection and treatment of diabetic eye diseases.
  • To emphasize the effectiveness of laser treatments in preventing vision loss.
  • To advocate for increased awareness among primary care physicians and diabetic patients.

Main Methods:

  • Review of findings from the Early Treatment Diabetic Retinopathy Study (ETDRS) and Diabetic Retinopathy Study (DRS).

Related Experiment Videos

  • Clinical examination of patients with diabetic retinopathy, including funduscopic examination with dilated pupils.
  • Analysis of treatment outcomes for focal laser photocoagulation and scatter laser photocoagulation.

    • Main Results:

    • Focal laser treatment effectively reduces vision loss in patients with diabetic macular edema by targeting leaking blood vessels.
    • Scatter laser treatment significantly reduces severe visual loss by at least 50% in patients with proliferative diabetic retinopathy.
    • Untreated proliferative diabetic retinopathy has a high likelihood of causing blindness.

    Conclusions:

    • Early intervention with focal laser treatment is crucial for managing diabetic macular edema.
    • Scatter laser treatment is a vital intervention for proliferative diabetic retinopathy to prevent severe vision loss.
    • Aggressive patient and physician education is necessary to eliminate preventable blindness caused by diabetes.